Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival
Sławomir Andrzejewski, Marie Winter, Leandro Encarnação Garcia, Olusiji Alex Akinrinmade, Francisco Madeira Marques, Emmanouil Zacharioudakis, Anna Skwarska, Julio A. Aguirre‐Ghiso, Marina Y Konopleva, Guangrong Zheng, Susan Fineberg, Daohong Zhou, Evripidis Gavathiotis, Tao Wang, Eugen Dhimolea
This study identifies OXPHOS-high quiescent triple-negative breast cancer cells that survive chemotherapy and depend on BCL-XL for survival, showing that targeting BCL-XL enhances chemotherapy efficacy.
Cells · Oct 8, 2025Peer-reviewedCancer Biology